The effect of osteopontin and osteopontin-derived peptides on preterm brain injury

DSpace/Manakin Repository

The effect of osteopontin and osteopontin-derived peptides on preterm brain injury

Citable link to this page

 

 
Title: The effect of osteopontin and osteopontin-derived peptides on preterm brain injury
Author: Albertsson, Anna-Maj; Zhang, Xiaoli; Leavenworth, Jianmei; Bi, Dan; Nair, Syam; Qiao, Lili; Hagberg, Henrik; Mallard, Carina; Cantor, Harvey; Wang, Xiaoyang

Note: Order does not necessarily reflect citation order of authors.

Citation: Albertsson, Anna-Maj, Xiaoli Zhang, Jianmei Leavenworth, Dan Bi, Syam Nair, Lili Qiao, Henrik Hagberg, Carina Mallard, Harvey Cantor, and Xiaoyang Wang. 2014. “The effect of osteopontin and osteopontin-derived peptides on preterm brain injury.” Journal of Neuroinflammation 11 (1): 197. doi:10.1186/s12974-014-0197-0. http://dx.doi.org/10.1186/s12974-014-0197-0.
Full Text & Related Files:
Abstract: Background: Osteopontin (OPN) is a highly phosphorylated sialoprotein and a soluble cytokine that is widely expressed in a variety of tissues, including the brain. OPN and OPN-derived peptides have been suggested to have potential neuroprotective effects against ischemic brain injury, but their role in preterm brain injury is unknown. Methods: We used a hypoxia-ischemia (HI)-induced preterm brain injury model in postnatal day 5 mice. OPN and OPN-derived peptides were given intracerebroventricularly and intranasally before HI. Brain injury was evaluated at 7 days after the insults. Results: There was a significant increase in endogenous OPN mRNA and OPN protein in the mouse brain after the induction of HI at postnatal day 5. Administration of full-length OPN protein and thrombin-cleaved OPN did not affect preterm brain injury. This was demonstrated with both intracerebroventricular and intranasal administration of OPN as well as in OPN-deficient mice. Interestingly, both N134–153 and C154–198 OPN-derived peptides increased the severity of brain injury in this HI-induced preterm brain injury model. Conclusions: The neuroprotective effects of OPN are age-dependent, and, in contrast to the more mature brain, OPN-derived peptides potentiate injury in postnatal day 5 mice. Intranasal administration is an efficient way of delivering drugs to the central nervous system (CNS) in neonatal mice and is likely to be an easy and noninvasive method of drug delivery to the CNS in preterm infants.
Published Version: doi:10.1186/s12974-014-0197-0
Other Sources: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4266908/pdf/
Terms of Use: This article is made available under the terms and conditions applicable to Other Posted Material, as set forth at http://nrs.harvard.edu/urn-3:HUL.InstRepos:dash.current.terms-of-use#LAA
Citable link to this page: http://nrs.harvard.edu/urn-3:HUL.InstRepos:13581204
Downloads of this work:

Show full Dublin Core record

This item appears in the following Collection(s)

 
 

Search DASH


Advanced Search
 
 

Submitters